Abstract 63P
Background
Colorectal cancer is one of the most common cancers in our country. Different clinicopathological features and outcome have been demonstrated between right and left CRC. In our study, we aim to characterize tumor sidedness, clinical profile and histological features of colorectal cancer to improve oncological care.
Methods
The data was retrospectively taken from Medical Oncology OPD Registry, YGH, over one year period from January, 2020 to December, 2020. Summary statistics were used to describe results.
Results
Total 225 (63 right side and 162 left side) patients were included in this study. Right sided tumor included from caecum to splenic flexure. Left sided one represented the remaining large bowel including rectum. The sites observed were caecum (6.6%), ascending colon (9.3%), hepatic flexure (6.6%), transverse colon (3.5%), splenic flexure (1.7%), descending colon (5.7%), sigmoid colon (7.5%), recto-sigmoid (12%) and rectum (46%) respectively. Mean age was 52 years, the youngest was 14 years and the oldest was 89 years. Forty percents of patients were <50 years of age. In right side, male patients (52%) were more than female patients (48%). In left side, slight female preponderance over male (51% Vs 49%) was seen. Presentation with intestinal obstruction or perforation was more commonly seen in right side (38%) than left side (22%). The most common histological subtype in both sides was moderately differentiated adenocarcinoma. Special subtype (mucinous and signet ring cell type) was more commonly seen in right side (24%) than left side (10.5%). More than 80% of patients came with advanced stage (stage III and IV) in both sides. The most common site of metastasis from both sides was peritoneum and liver.
Conclusions
In this study, there were more patients with left-sided CRC than right-sided. And like other countries, the burden of disease in younger patients is quite concerning. As most patients were diagnosed at advanced stage, necessary interventions for CRC awareness should be promoted. This study also highlights that clinicopathological differences exist between right and left colorectal cancer, possibly indicating prognostic significance that might improve the oncological care.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
48P - Long-term clinical outcomes after the second metastasectomy in patients (pts) with resected metastatic colorectal cancer (mCRC)
Presenter: Songji Choi
Session: Poster viewing 02
49P - Ramucirumab beyond progression plus TAS 102 in patients with advanced or metastatic adenocarcinoma of the stomach or the gastroesophageal junction, after treatment failure on a ramucirumab based therapy: Final results of the phase II RE-ExPEL study
Presenter: Thorsten Goetze
Session: Poster viewing 02
50P - Linear tumor regression of rectal cancer in daily MRI during preoperative chemoradiotherapy: An insight of tumor regression velocity for personalized cancer therapy
Presenter: Sea-Won Lee
Session: Poster viewing 02
51P - Efficacy and safety of sintilimab as first-line therapy in patients with microsatellite instability-high metastatic colorectal cancer: A real-world study
Presenter: Caiyun Nie
Session: Poster viewing 02
53P - Baseline PET/CT deep radiomics signature apply for identifying bevacizumab sensitivity of RAS-mutant colorectal cancer liver metastases patients
Presenter: Wenju Chang
Session: Poster viewing 02
54P - Efficacy of total neoadjuvant therapy (TNT) in rectal cancer: A meta-analysis of randomized controlled trials
Presenter: Yakup Ergün
Session: Poster viewing 02
55P - Biodegradable and biocompatible 3D-printed scaffolds loaded with chemotherapy drugs: A new horizon for treatment of colon cancer with diffuse intraperitoneal metastasis
Presenter: Amirhosein Kefayat
Session: Poster viewing 02
56P - Clinico-pathological profile of adolescent and young adult colorectal cancer patients: Multicentre collaborative registry data from India
Presenter: Soumya Surath Panda
Session: Poster viewing 02